期刊文献+

银屑病患者外周血单个核细胞端粒酶活性及与疾病严重程度的关系 被引量:1

Relationshop Between Telomerase Activity in PBMC of Psoriatic Patients and Disease Severity
下载PDF
导出
摘要 目的探讨银屑病患者外周血单个核细胞(PBMC)端粒酶活性及与疾病严重程度和病程的关系。方法分离银屑病患者和正常人外周血单个核细胞,采用聚合酶链反应-酶联免疫吸附(PCR-ELISA)法检测寻常型银屑病患者和正常人外周血单个核细胞的端粒酶活性水平;用银屑病皮损严重程度指数(PASI)评价银屑病患者病情严重程度。结果银屑病组PBMC的端粒酶活性(0.9±0.18)较正常组(0.49±0.11)显著升高(t=8.096,P<0.01),进行期(0.97±0.19)高于消退期或静止期(0.90±0.17),端粒酶活性与疾病严重程度成正相关(r=0.889,P<0.001),而与病程无明显线性关系。结论银屑病患者外周血单个核细胞端粒酶活性水平升高,且与疾病严重程度成正相关,而与病程无关,可作为银屑病发病及病情判定的一个指标。 Objective To detect the telomerase activity in peripheral blood mononuclear cells (PBMC) from psoriatic patients, and explore its correlation with psoriasis area and severity index (PASI) and duration. Methods Telomerase activity in PBMC of blood obtained from a total 19 psoriatic patients and 13 normal controls were determined by PCR-ELISA method. Results The telomerase activity was significantly higher in PBMC of psoriatic patients (0.94 ± 0.18 ) than thase in normals (0.49 ± 0.11 ) (t = 8. 096, P 〈 0.001 ). Patients with progressive psoriasis displayed higher levels of telomerase activity (0.97 ± 0.19 ) than whom wich remissive or static psoriasis (0.90 ± 0.17 ), but without statistical significance. A correlation between telomerase activity of PBMC and PASI score( r = 0. 889 ,P 〈0.001 )was found ,but no correlation between telomerase activity and duration. Conclusion Telomerase activity of PBMC correlates very well with the severity of psoriasis but nou relationship duration,and may be it is a sensitive marker of disease severity.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2006年第6期327-329,共3页 The Chinese Journal of Dermatovenereology
基金 辽宁省自然科学基金资助项目(编号2040736)
关键词 银屑病 端粒酶 PBMC PASI Psoriasis Telomerase PBMC PASI
  • 相关文献

参考文献8

  • 1Hiyama K,Hirai Y,Kyoizumi S,et al.Activation of telomerase in human lymphocytes and hematopoietic progenitor cells[J].J Immunol,1995,155(10):3711-3715.
  • 2Bodnar AG,Kim NW,Effros RB,et al.Mechanism of telomerase induction during T cell activation[J].Exp Cell Res,1996,228(1):58-64.
  • 3Bonifati C,Ameglio F.Cytokines in psoriasis[J].Int J Dermatol,1999,38(4):241-251.
  • 4Kaida Wu,Naoyuki Higashi,Erik Rene Hansen,et al.Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis[J].J Immunol,2000,165(8):4742-4747.
  • 5黄燕,范学工,唐发清,易红.正常人淋巴细胞端粒酶活性的观察[J].中国免疫学杂志,2000,16(9):500-502. 被引量:2
  • 6Bagel J,Garland WT,Breneman D,et al.Administration of DBA389IL-2 to patients with recalcitrant psoriasis:a double-blind,phase П multicenter trial[J].J Am Acad Dermatol,1998,38(6):938-944.
  • 7Duocan JI,Horrocks C,Ormerod AD,et al.Soluble IL-2 receptor and CD25 cells in psoriasis:effects of cyclosporin A and PUVA therapy[J].Clin Exp Immunol,1991,85 (2):293-296.
  • 8Exum ML,Rapp SR,Feldman SR,et al.Measuring severity of psoriasis:methodological issues[J].J Dermatol Treat,1996,7(2):119-124.

二级参考文献1

共引文献1

同被引文献24

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部